Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children

Completed · Phase 3

Conditions studied: Growth Hormone Disorder, Pituitary Dwarfism

In brief

This trial is conducted in the United States of America (USA). This is a 12 month study to determine if Norditropin is safe and effective in children with IGF deficiency.

Key facts

Study ID

NCT00102817

Run by

Novo Nordisk A/S

People needed

149

Starts

2003-05-01

Expected to finish

2006-12-01

Last updated by the study team

2017-01-18

Who can join

Age: 3 and older, up to 13. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ages 3-15
• Presence of growth failure indicated by height standard deviation score less than equal to -2
• Body mass index greater than or equal to 25th percentile for height age
• IGF concentration less than or equal to 33rd percentile

Where it is running

• Novo Nordisk Investigational Site — Los Angeles, California, United States
• Novo Nordisk Investigational Site — San Diego, California, United States
• Novo Nordisk Investigational Site — Stanford, California, United States
• Novo Nordisk Investigational Site — St. Petersburg, Florida, United States
• Novo Nordisk Investigational Site — Tallahassee, Florida, United States
• Novo Nordisk Investigational Site — Tampa, Florida, United States
• Novo Nordisk Investigational Site — Indianapolis, Indiana, United States
• Novo Nordisk Investigational Site — Boston, Massachusetts, United States
• Novo Nordisk Investigational Site — Worcester, Massachusetts, United States
• Novo Nordisk Investigational Site — Kalamazoo, Michigan, United States
• Novo Nordisk Investigational Site — Minneapolis, Minnesota, United States
• Novo Nordisk Investigational Site — Kansas City, Missouri, United States
• Novo Nordisk Investigational Site — Brooklyn, New York, United States
• Novo Nordisk Investigational Site — Buffalo, New York, United States
• Novo Nordisk Investigational Site — Rockville Centre, New York, United States
• Novo Nordisk Investigational Site — The Bronx, New York, United States
• Novo Nordisk Investigational Site — Akron, Ohio, United States
• Novo Nordisk Investigational Site — Cincinnati, Ohio, United States
• Novo Nordisk Investigational Site — Oklahoma City, Oklahoma, United States
• Novo Nordisk Investigational Site — Hershey, Pennsylvania, United States
• Novo Nordisk Investigational Site — Philadelphia, Pennsylvania, United States
• Novo Nordisk Investigational Site — Philadelphia, Pennsylvania, United States
• Novo Nordisk Investigational Site — Pittsburgh, Pennsylvania, United States
• Novo Nordisk Investigational Site — Columbia, South Carolina, United States
• Novo Nordisk Investigational Site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.